Infrastructure company Larsen & Toubro (L&T) on Wednesday said it has received multiple orders across various business segments in the domestic market.

The company did not provide the value of the contracts but said the orders fall under the “large” category, which ranges between Rs 2,500 crore and Rs 5,000 crore according to its classification of contracts.

“The construction arm of L&T has secured orders from prestigious clients for its varied businesses,” L&T said in a regulatory filing.

The company said its buildings and factories business has won orders from a reputed developer to construct a high rise residential project and an office space in Mumbai.

The factories business has received an order from a leading global shipping and logistic company for the design and construction of warehousing logistics park at Mumbai and also secured an order

With yet another net decline on Tuesday, India’s count of active coronavirus cases came down to 748,538, which is fewer than France’s tally of 770,719 and the US’ 2,728,163. With sub-600 Covid-19 fatalitities for consecutive days – 587 reported on Tuesday – India’s death toll reached 115,197, while 69,720 cured cases pushed the country’s total recovered cases to 6,733,328, or 88.63 per cent of all confirmed infections so far. The country has reported as many as 1,545,503 cured coronavirus cases in October so far.

Overall, an addition of 46,790 cases – the lowest single-day spike since July 23 – took India’s tally of confirmed cases to 7,597,063.

The third-most-affected country by active cases and fatality, and second by total cases, India has added 421,183 in the past seven days. Here are the key takeaways from the coronavirus data released by the Union Ministry of

Antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the novel coronavirus, and symptoms have subsided, according to a study.

In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe symptoms with blood plasma from recovering patients.

If convalescent plasma is ultimately shown to have a clear benefit, the new study published in the journal mBio concluded that it needs to be collected during a specific window of time after recovery.

However, recovering patients can’t donate blood until at least 14 days after symptoms have subsided, to give the body time to clear viral particles.

“We don’t want to transfuse the virus, just transfuse the antibodies,” said Andres Finzi at the University of Montreal in Canada.

“But at the